A body of epidemiological literature has suggested an association between prenatal infection, subsequent maternal immune activation (MIA), and later risk of schizophrenia. These epidemiological studies have inspired preclinical research using rodent and primate models of prenatal infection and MIA. The findings from these preclinical studies indicate that severe infection and immune activation during pregnancy can negatively impact offspring brain development and impair adult behavior. This review aims to summarize the major epidemiological and preclinical findings addressing the connection between prenatal infection and immune activation and later risk of developing schizophrenia, as well as the more limited literature addressing the mechanisms by which this gestational insult might affect offspring neurodevelopment. Finally, directions for future research will be discussed. 
Introduction
In recent decades it has become increasingly accepted that schizophrenia is a disorder of Finally, directions for future research will be discussed.
Epidemiological studies
Early ecological studies identifying prenatal infection as a risk factor for schizophrenia used naturally occurring epidemics to query an association between in utero exposure to infection and later development of this psychiatric disorder (for review, see [2] ). In Finnish, Danish and English populations, the occurrence of schizophrenia was higher among offspring in utero during influenza epidemics than among offspring in utero during comparable non-epidemic periods [6] [7] [8] [9] . However, the effect sizes for these associations were small and the findings were not consistently replicated [10] [11] [12] [13] . In all of these studies, seropositivity for a particular infection was defined as having an IgG antibody titer against that pathogen greater than a given cut-off value. In one study, based on the CHDS birth cohort, influenza antibody levels above a threshold value were shown to correlate with acute infection as measured by seroconversion using a comparison of IgG levels across multiple blood draws [14] , but this Studies from all three cohorts found an increased risk of psychosis or schizophrenia among offspring whose mothers were seropositive for a number of different pathogens during pregnancy. A nested case-control study drawn from the CHDS cohort demonstrated that serologically documented exposure to influenza during the first half of pregnancy was linked to a 3-fold increase in risk of developing schizophrenia; for exposure occurring in the first trimester, the increase in risk was 7-fold [14] . In the CHDS cohort, offspring of women with the highest level (upper decile) of IgG antibody to Toxoplasma gondii had a 2.6-fold increase in risk of developing schizophrenia [15] . This association was replicated in a Danish cohort that used neonatal levels of Toxoplasma IgG measured on filter paper blood spots to infer prenatal maternal Toxoplasma IgG levels; subjects with IgG levels in the upper quartile were at a 1.78-fold increased risk of developing early-onset schizophrenia [16] . In the CPP Rhode Island cohort, a small case-control study demonstrated that offspring with affective or non-affective psychoses had mothers with significantly elevated levels of serum IgG antibody against HSV-2 at term [17] . This finding was subsequently replicated in a larger case-control study drawn from three different CPP sites (Boston, Philadelphia and Providence)
where offspring of mothers with elevated levels of serum IgG antibody against HSV-2 at term were at a 1.6-fold increased risk of developing these disorders [18] .
There were also some discordant findings among these three different birth cohorts. For example, the association between prenatal seropositivity for HSV-2 and increased risk of schizophrenia was not replicated in the CHDS cohort [19] . Additionally, the CPP analysis that showed elevated levels of HSV-2 antibody in the maternal serum of mothers of schizophrenia patients failed to detect an increase in IgG antibody to Toxoplasma gondii [17] , as was seen in the CHDS and Danish birth cohort studies described above. Regarding showed that prenatal exposure to influenza or Toxoplasma gondii was associated with impairment in executive function in adult patients with schizophrenia [24] . In a second study from the DIBS, exposure to maternal genital-reproductive infections was related to verbal and neuromotor deficits in adult schizophrenia patients [25] . Moreover, maternal infection was associated in that cohort with increased size of the cavum septum pellucidum, a replicated neuromorphologic finding in schizophrenia that has embryologic origins [26] .
Ongoing studies which capitalize on data from large national registries, such as the 
Preclinical studies
The earliest animal model of prenatal infection was one in which pregnant mice were directly infected with influenza virus via intranasal infusion [30, 31] . 
developmental origins of neurobiological abnormalities
Intriguingly, many immune signaling proteins also play a role in central nervous system development and plasticity (for review see, [56, 57] ). During development, cytokines such as leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF), members of the epidermal growth factor (EGF) family, neuregulin 1 (NRG1) and transforming growth factor β (TGFβ) have been shown to affect neurogenesis and neuronal differentiation [56] . Furthermore, the chemokine, CXCL12 (also called SDF-1), has been shown to be critical for cell migration as well as axon guidance and path-finding [58] [59] [60] . Regarding plasticity, the inflammatory cytokine, TNFα, has been found to be important for modulating glutamatergic synaptic strength and also for homeostatic synaptic scaling in response to changes in network activity [61, 62] .
The complement protein, C1q, has been shown to be critical for efficient synaptic pruning, along with other immune signaling molecules, such as those of the major histocompatibility complex 1 (MHC-1) [63, 64] [27, 28] .
Second, preclinical studies have indicated that MIA results in greatly increased levels of cytokines in the maternal serum and the placenta [32, 65] . Finally, in one study, injection of the cytokine, IL-6, is sufficient to recapitulate several of the behavioral abnormalities associated with prenatal administration of Poly IC [34] .
In that same study, blocking maternal IL-6 production prevented the development 
Gene-environment interactions
Clearly, the prevalence of infection during pregnancy is much higher than that of schizophrenia. Thus, it is a pressing question 
